
Treated patients also had fewer post-acute hospitalizations and deaths, but individuals without risk factors saw no benefit.
Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on what can be done now to avoid complications while administering the coronavirus disease 2019 (COVID-19) vaccine.
Pharmacy Times® interviewed Rob LaHayne, the CEO of TouchCare, on what can be done now to avoid complications while administering the coronavirus disease 2019 (COVID-19) vaccine.
For the full conversation, see the video above.






